Get started
ClearPoint Neuro Inc.ClearPoint Neuro Inc.ClearPoint Neuro Inc.

ClearPoint Neuro Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

CLPT chart


Full chart

CLPT upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪370.73 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.70 USD
Net income (FY)
‪−18.91 M‬ USD
Revenue (FY)
‪31.39 M‬ USD
Shares float
‪24.14 M‬
Beta (1Y)
1.54

Employees


Employees (FY)
115
Change (1Y)
+8 +7.48%
Revenue / Employee (1Y)
‪272.96 K‬ USD
Net income / Employee (1Y)
‪−164.47 K‬ USD

About ClearPoint Neuro Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Joseph Michael Burnett
Website
clearpointneuro.com
Headquarters
Solana Beach
Founded
1998
FIGI
BBG000Q39HV3
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CLPT news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as CLPT.

Frequently Asked Questions


The current price of CLPT is 14.21 USD — it has increased by 4.08% in the past 24 hours. Watch ClearPoint Neuro Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ClearPoint Neuro Inc. stocks are traded under the ticker CLPT.
CLPT stock has risen by 9.88% compared to the previous week, the month change is a 0.29% rise, over the last year ClearPoint Neuro Inc. has showed a 157.34% increase.
We've gathered analysts' opinions on ClearPoint Neuro Inc. future price: according to them, CLPT price has a max estimate of 30.00 USD and a min estimate of 20.00 USD. Watch CLPT chart and read a more detailed ClearPoint Neuro Inc. stock forecast: see what analysts think of ClearPoint Neuro Inc. and suggest that you do with its stocks.
CLPT reached its all-time high on Jul 3, 2012 with the price of 200.00 USD, and its all-time low was 1.33 USD and was reached on Dec 26, 2018. View more price dynamics on CLPT chart.
See other stocks reaching their highest and lowest prices.
CLPT stock is 9.51% volatile and has beta coefficient of 1.54. Track ClearPoint Neuro Inc. stock price on the chart and check out the list of the most volatile stocks — is ClearPoint Neuro Inc. there?
Today ClearPoint Neuro Inc. has the market capitalization of ‪370.73 M‬, it has increased by 6.71% over the last week.
Yes, you can track ClearPoint Neuro Inc. financials in yearly and quarterly reports right on TradingView.
ClearPoint Neuro Inc. is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
CLPT earnings for the last quarter are −0.20 USD per share, whereas the estimation was −0.16 USD resulting in a −22.05% surprise. The estimated earnings for the next quarter are −0.16 USD per share. See more details about ClearPoint Neuro Inc. earnings.
ClearPoint Neuro Inc. revenue for the last quarter amounts to ‪7.77 M‬ USD, despite the estimated figure of ‪8.23 M‬ USD. In the next quarter, revenue is expected to reach ‪8.21 M‬ USD.
CLPT net income for the last quarter is ‪−5.39 M‬ USD, while the quarter before that showed ‪−4.97 M‬ USD of net income which accounts for −8.28% change. Track more ClearPoint Neuro Inc. financial stats to get the full picture.
No, CLPT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 24, 2025, the company has 115 employees. See our rating of the largest employees — is ClearPoint Neuro Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ClearPoint Neuro Inc. EBITDA is ‪−17.84 M‬ USD, and current EBITDA margin is −56.84%. See more stats in ClearPoint Neuro Inc. financial statements.
Like other stocks, CLPT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ClearPoint Neuro Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ClearPoint Neuro Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ClearPoint Neuro Inc. stock shows the buy signal. See more of ClearPoint Neuro Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.